Apellis Pharmaceuticals, Inc. (APLS)
20.07
-0.08
(-0.40%)
USD |
NASDAQ |
Mar 06, 16:00
20.08
+0.01
(+0.05%)
After-Hours: 20:00
Apellis Pharmaceuticals SG&A Expense (TTM) : 550.26M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amneal Pharmaceuticals, Inc. | 526.83M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Amicus Therapeutics, Inc. | 383.49M |
| Ionis Pharmaceuticals, Inc. | 393.68M |